PORTFOLIO NEWS Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise June 12, 2020 Read More » Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 June 9, 2020 Read More » Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration June 4, 2020 Read More » Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock May 28, 2020 Read More » Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board May 27, 2020 Read More » Arcus Biosciences and Gilead Sciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies May 27, 2020 Read More » NGM Bio Appoints Siobhan Nolan Mangini as Chief Financial Officer May 27, 2020 Read More » ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results May 20, 2020 Read More » RAPT Therapeutics Reports First Quarter 2020 Financial Results May 14, 2020 Read More » Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress May 14, 2020 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise June 12, 2020 Read More »
Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 June 9, 2020 Read More »
Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration June 4, 2020 Read More »
Arcus Biosciences, Inc. Announces Pricing of $302.5 Million Underwritten Public Offering of Common Stock May 28, 2020 Read More »
Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board May 27, 2020 Read More »
Arcus Biosciences and Gilead Sciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies May 27, 2020 Read More »
ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results May 20, 2020 Read More »
Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress May 14, 2020 Read More »
